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Using a promyelocytic leukemia cell line, HL-60, we studied the membrane transport of Ara-C before and after differen- 
tiation induced by retinoic acid (RA). In RA-treated cells, Ara-C transport was reduced and there was a concomitant 
increase of the ID,, values of Ara-C in comparison with the controls. By three different procedures to synchronize un- 
treated cells, i.e. density arrest G, phase enrichment, aphidicolin-induced S phase accumulation and the double isoleucine 
block method, we found that Ara-C transport was 3@50% higher in the S phase than in the G, phase. Therefore, the 
observed decrease in Ara-C transport is, in part, due to the retarded growth accompanied by an accumulation of cells 
in the G, phase after differentiation induction. 
Arabinofuranosylcytosine transport; Differentiation; Cell cycle 
1. INTRODUCTION 
The efficacy of chemotherapy for leukemia is 
usually related to the degree of maturation arrest 
of the neoplastic clones. That is, leukemia cells 
with a mature phenotype are more resistant o an- 
ticancer agents. From this point of view, the rela- 
tionship between cell differentiation and drug 
sensitivity is a clinically important issue. Recently, 
we demonstrated that human T-lymphoblastoid 
cell line MOLT-4 cells became resistant to l-,&D- 
arabinofuranosylcytosine after differentiation in- 
duced by TPA, and this acquired resistance was at- 
tributed in part to a decrease in the membrane 
transport of Ara-C [ 11. The doubling time of TPA- 
treated MOLT-4 cells was 2.6-fold that of the con- 
trols, and in accordance with the retarded growth, 
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an accumulation of cells in the Gi phase was 
observed following differentiation. 
Therefore, to determine whether such reduction 
of Ara-C transport in differentiated cells is due to 
the altered cell cycle distribution, we evaluated cell 
cycle-related changes in nucleoside transport. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
The human promyelocytic ell line HL-60 was cultivated in 
RPM1 1640 medium supplemented with 10% heat inactivated 
fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, 
and lOOrg/ml streptomycin. Cultures were kept at 37°C in a 
humidified incubator in a 95% air/W0 CO2 atmosphere. The 
cells were checked regularly for mycoplasma contamination. 
For differentiation induction, cells (1 x lO’/ml) were exposed 
to 1 bM RA for four days. Then, the ability of cells to reduce 
nitroblue tetrazolium dye was evaluated as an indicator of dif- 
ferentiation. 
2.2. Drug sensitivity 
Cells (2 x lO’/ml) were cultured in media containing serial 
dilutions of several nucleosides: Ara-C, Ara-A and CdA. After 
48 h of incubation, the concentration of the nucleosides re- 
quired to inhibit growth by 50% (IDso) was determined by 
trypan blue dye exclusion. 
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2.3. Determination of Ara-C transport Table 1 
The membrane transport of Ara-C was evaluated by the 
silicon-oil technique described in our earlier report [I]. 
Sensitivity of HL-60 cells to several nucleoside analogs before 
and after differentiation induction 
2.4. Cell synchronization and cell cycle analysis 
Cell synchronization was achieved by three different pro- 
cedures. The percentage of cells in each phase of the cell cycle 
was determined with a FACS 440 (Becton-Dickinson) [I]. First, 
the proliferation of HL-60 cells was arrested by making the cell 
density approx. 2 x 106/ml. One day later, when more than 
75% of the cells had accumulated in the Gr phase, termed the 
‘confluent phase’, the transport assay was performed. 
Treatment 
Ara-C 
IDJO (M) 
Ara-A CdA 
None 3.8 x IO-* 2.7 x 1O-6 4.5 x IO-* 
1 NM retinoic acid 1.7 x 10-6 3.4 x 10-s 3.5 x 10-s 
Second, the double isoleucine block method, described in an 
earlier report [2] was used. Following release from the second 
isoleucine starvation, cultures were pulse-labeled with 
[methyl-.‘H]thymidine at 1 h intervals up to 24 h and the incor- 
poration of thymidine into DNA was measured. 
Finally, the cells were synchronized in the S phase by 24 h 
treatment with 0.2rg/ml aphidicolin, an inhibitor of DNA 
polymerase (Y [3]. Ara-C transport was evaluated 3 h after the 
removal of aphidicolin, when almost 100% of the cells were in 
the S phase. 
transport of Ara-C in RA-treated HL-60 cells fell 
to about 50-60070 of the control value irrespective 
of the extracellular concentration of Ara-C (fig. 1). 
The affinity constant (K,,,; the concentration of 
substrate required to achieve half-maximal 
transport) determined graphically from Line- 
weaverBurk plots did not show significant change 
between control and RA-treated cells (3.4 f 
1.1 PM and 4.4 f 1.6 ,uM, respectively). 
3. RESULTS 
3.1. Ara-C transport before and after 
differentiation 
After four days of treatment with RA, HL-60 
cells stopped proliferating and more than 90% 
showed a positive reaction in the nitroblue 
tetrazolium dye reduction test. Concomitantly, the 
20 
v) 
= 
8 I / 
0 20 40 60 120 
Time (see> 
Fig. 1. A representative time course of the transport of [‘H]Ara- 
C in RA-treated (open symbols) and untreated (closed symbols) 
HL-60 cells. The extracellular Ara-C concentrations are 5 ,uM 
(e,~), 1 PM (A, A) and 0.2,~M (m, 0). 
3.2. Drug sensitivity 
The IDso values of three synthetic nucleosides 
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Fig.2. Transport of 1 pM [‘H]Ara-C by wild type cells (a) and 
mutant cells deficient in deoxycytidine kinase (0). 
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(Ara-C, Ara-A, CdA) are shown in table 1. Cells 
became approximately lo-220-fold more resistant 
to the drugs after RA-induced differentiation. 
3.3. Ara-C transport in mutant cells deficient in 
deoxycytidine kinase 
After entry into cells, Ara-C is rapidly converted 
to Ara-CTP. Deoxycytidine kinase (dCK) is the 
first and the rate-limiting step of this process. 
Therefore, we evaluated Ara-C transport in HL-60 
mutant cells deficient in dCK to examine the 
possibility that the intracellular metabolism of 
Ara-C may affect the transport rates. The mutant 
was selected in our laboratory on the basis of being 
resistant to Ara-C, and it contained less than 1% 
of the dCK activity of wild type cells [4]. As shown 
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Fig.3. [‘H]Thymidine incorporation into DNA after release 
from isoleucine starvation (4) in HL-60 cells synchronized by 
the double isoleucine block method (upper panel). At the 
indicated times (A,B), Ara-C transport was examined (lower 
panel). 
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Fig.4. Ara-C transport of aphidicolin (0.2/cg/ml for 24 h)- 
treated (0) and untreated (0) HL-60 cells. The assay was 
performed 3 h after the removal of aphidicolin. 
in fig.2, Ara-C transport in mutant cells was 
almost equivalent o that in the parent cells. This 
was also true even after RA-induced differentia- 
tion (data not shown). 
3.4. Changes of Ara-C transport during the cell 
cycle 
First, we evaluated Ara-C transport in density- 
arrested HL-60 cells. A decrease of about 50% in 
Ara-C transport was observed in a confluent phase 
compared to that in a logarithmic phase. Next, 
cells were initially synchronized in the GI phase by 
the double isoleucine block method. Ara-C 
transport increased for cells to traverse the cell cy- 
cle after the replacement of isoleucine. Indeed, 
when the phases of the cell cycle were defined by 
[3H]thymidine incorporation into DNA, Ara-C 
transport was about 1.5times greater in the S 
phase than in the Gi phase. Third, synchronization 
in the S phase was performed by treatment with 
0.2 rg/ml aphidicolin. Ara-C transport was also 
significantly greater in the synchronized S phase- 
rich cells (fig.4). 
4. DISCUSSION 
In the present study, we demonstrated that the 
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transport of Ara-C in HL-60 leukemia cells 
decreased after RA-induced differentiation, which 
was accompanied by an increase of the IDSO value 
of Ara-C and the other nucleosides. Mutant cells 
deficient in dCK followed the same time course of 
Ara-C transport as that of wild type cells. This fact 
suggests that the change in dCK activity, if any, 
does not explain the altered Ara-C transport after 
differentiation. 
This is further supported by the observation that 
the number of nitrobenzylthioinosine-binding sites 
per cell increased as cells progressed from the Gr 
through the S phase in HeLa cells [8]. 
Finally, our present results suggest one possible 
biochemical basis for the reduced sensitivity to 
various nucleoside analogs in more differentiated 
leukemia. 
There have been several studies showing that 
nucleoside transport is reduced during cellular dif- 
ferentiation [5,6]. Chen et al. reported that a 
decrease in the number of specific binding sites per 
cell for a given nucleoside was related to the reduc- 
tion of transport in differentiation-induced HL-60 
cells [6]. In general, cell differentiation and arrest 
of proliferation is a coupled process [7]. Actually, 
HL-60 cells stopped growing four days after RA 
treatment. Such alteration in the growth 
characteristics is inevitably accompanied by a 
change in cell cycle distribution; namely, an ac- 
cumulation of cells in the Gr phase with a concomi- 
tant decrease in the S and GZ + M phases [l]. 
Therefore, our finding that Ara-C transport in 
HL-60 cells decreases in the Gr phase and increases 
in the S phase suggests that the decrease in 
nucleoside transport following differentiation is, 
in part, a function of altered cell cycle distribution. 
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